| Mazen Dahan, MD | |
|
1420 3rd St Se Ste 200, Puyallup, WA 98372-3730 | |
| (253) 848-7660 | |
| (253) 841-1801 |
| Full Name | Mazen Dahan |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1420 3rd St Se Ste 200, Puyallup, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578671830 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD00038984 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mazen Dahan, MD 1420 3rd St Se Ste 200, Puyallup, WA 98372-3730 Ph: (253) 848-7660 | Mazen Dahan, MD 1420 3rd St Se Ste 200, Puyallup, WA 98372-3730 Ph: (253) 848-7660 |
News Archive
Scientists from Far Eastern Federal University, V.I. Vernadsky Crimean Federal University, Dmitry Mendeleev University of Chemical Technology, and Far Eastern Branch of the Russian Academy of Sciences, assumed the risks of primary skin cancer and its recurrences can be significantly reduced by applying the ointment with antisense oligonucleotides which are short DNA, RNA fragments used in oncology to suppress the synthesis of tumor proteins.
Pharmalink AB announced today that it has been granted Japanese Patent No 4326696, "Methods and means for treating glomerulonephritis" for its product Nefecon(R) which is being developed to treat IgA nephropathy, a glomerulonephritis leading to end-stage renal disease (ESRD). Counterparts of the patent have been issued for other territories including the EU, US and China.
Most people consume far too much salt, and a University of Iowa researcher has discovered one potential reason we crave it: it might put us in a better mood.
InNexus Biotechnology Inc. (TSX.V: IXS) (www.ixsbio.com), a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the development of a new psoriasis product based on its proprietary dermal permeating Transmab™ technology.
The World Health Organization (WHO) and influenza experts worldwide are concerned that the recent appearance and widespread distribution of an avian influenza virus (Influenza A/H5N1) has the potential to ignite the next pandemic and potentially kill millions.
› Verified 6 days ago
Mr. Michael Lane Pearson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 12904 94th Ave East, Puyallup, WA 98373 Phone: 253-841-3999 Fax: 253-841-7311 | |
Angela A Viniarski, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1706 Meridian S, Suite 120, Puyallup, WA 98371 Phone: 253-848-8797 Fax: 253-446-3239 | |
Andrew T Sledd, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1007 39th Ave Se, Puyallup, WA 98374 Phone: 253-435-3100 Fax: 253-435-3298 | |
Dr. Victoria Devere, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1700 5th St Se, Puyallup, WA 98372 Phone: 253-848-8797 | |
Roselynn Wee Sim Cuenca, M.D., M.P.H. Pediatrics Medicare: Medicare Enrolled Practice Location: 1910 Meridian St S, Ste A, Puyallup, WA 98371 Phone: 253-848-2303 | |
Edward J Husarik, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1706 Meridian S, Suite 120, Puyallup, WA 98371 Phone: 253-848-8797 Fax: 253-446-3239 | |
Taylor Ryan Mclain, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 11102 Sunrise Blvd E Ste 103, Puyallup, WA 98374 Phone: 253-848-8797 |